This paper develops a predictive mathematical model of cell infection, host immune response and viral replication that reproduces observed long-term trends in human immunode¢ciency virus (HIV) pathogenesis. Cell activation induced by repeated exposure to many di¡erent antigens is proposed as the principal mechanism of providing target cells for HIV infection and, hence, of CD4 + T cell depletion, with regulation of the overall T cell pool size causing concomitant CD8 pool increases. The model correctly predicts the cross-patient variability in disease progression, the rate of which is found to depend on the e¤cacy of anti-HIV cytotoxic T lymphocyte responses, overall viral pathogenicity and random e¡ects. The model also predicts a variety of responses to anti-viral therapy, including episodic residual viral replication and discordant responses and we ¢nd that such e¡ects can be suppressed by increasing the potency of treatment.
INTRODUCTION
Much progress has been made in recent years in characterizing human immunode¢ciency virus (HIV) replication within an infected patient (reviewed by Fauci et al. 1996; Haase 1999) , its e¡ect on T cell kinetics (Fleury et al. 1998; Pakker et al. 1998; Hellerstein et al. 1999) , immunocompetence (reviewed in Powderly 1999 ) and the e¡ect of anti-retroviral drug treatment in suppressing viral burden and slowing the progression to disease (Ho et al. 1995; Wei et al. 1995; Mocroft et al. 1998; Palella et al. 1998; Ledergerber et al. 1999) . In some instances, the biological and population level processes underlying individual aspects of these dynamics are at least partly understood (reviewed by Finzi & Siliciano 1998) . However, a comprehensive explanation of the long-term progression of HIV infection and the processes giving rise to acquired immune de¢ciency syndrome (AIDS) remains elusive, given the complexity and multifactorial nature of the interactions involved.
Here we derive an integrated population dynamic framework for characterizing the interactions between CD4 + and CD8 + T cells, HIV and other pathogens. This framework, which is schematically outlined in ¢gure 1, extends existing work on HIV viral dynamics (for excellent reviews of past theoretical work see Perelson & Nelson (1999) and Nowak & May (2000) ). Our model is based on a small number of simple biological assumptions and generates dynamics that are in good agreement with observed patterns. In particular, the model explains the following.
(i) How the short time-scale (hours^days) processes of viral production, infection and clearance (Perelson et al. 1996) and of T cell activation and division (Stevenson et al. 1990 ) interact with the longer timescale (weeks) of the immunological process of antigen clearance to produce the very long timescale (years) of HIV pathogenesis. (ii) The highly variable but stable progression of HIV disease as measured by declines in peripheral CD4 + T cell numbers and matching increases in CD8 + T cell numbers (Margolick et al. 1995) . (iii) The observed correlation between set-point viral load and the duration of the asymptomatic period (Mellors et al. 1996; De Wolf et al. 1997 ). (iv) The variability in viral load both within and between patients. (v) The very low prevalence of infected cells throughout the course of infection (Chun et al. 1997 ). (vi) The relatively late onset of severe immunode¢ciency that characterizes the development of AIDS (Powderly 1999 ).
The work also gives new insights into the interaction between anti-viral therapy and anti-HIV responses, which suggest that the degree of inhibition required for suppressing residual viral replication may be signi¢cantly larger than previously estimated (Ferguson et al. 1999) .
Our analysis suggests that long-term HIV pathogenesis is the result of interactions between four key biological factors.
(i) The e¡ect of HIV in turning antigen-induced CD4 + T cell activation from a process that replenishes the quiescent cell pool into one that depletes it. (ii) Spatially localized invasion of non-HIV pathogens that leads to a steady rate of antigen-speci¢c T cell activation.
(iii) Homeostatic regulation of the overall T cell pool size that is blind to CD4 and CD8 surface markers, leading to gradual competitive exclusion of CD4 + T cells by CD8 + T cells under the ¢tness disadvantage caused by HIV infection. (iv) Anti-HIV cytotoxic T lymphocyte (CTL) responses that regulate but do not clear HIV.
Our view that patients' development of AIDS is not a result of sudden catastrophic changes but rather a steady progression to disease is supported by study of patient cohorts (Mellors et al. 1996; de Wolf et al. 1997; Lepri et al. 1997; Lyles et al. 1999) .
T CELL DYNAMICS
Key to the model framework is that antigen-driven T cell activation is the principal driving process determining the natural history of HIV infection. Regular exposure to environmental, commensal and HIV antigens ensures a steady rate of CD4 + T cell activation, thereby providing target cells for HIV infection (Stevenson et al. 1990; Zack et al. 1990 ). The e¡ect of T cell activation in enhancing viral replication is well established (Orendi et al. 1998) and its role in accelerating disease progression has been explored experimentally (Staprans et al. 1995; Ostrowski et al. 1998; Hazenberg et al. 2000a,b; Moriuchi et al. 2000) . A positive correlation has been demonstrated in several patient cohorts Phillips et al. 1996; Liu et al. 1997; Fahey et al. 1998; Giorgi et al. 1999) . The interaction between antigenic stimulation and viral dynamics has been explored extensively in earlier mathematical studies (Cooper 1986; McLean & Nowak 1992; Essunger & Perelson 1994; Mittler et al. 1996; Grossman et al. 1998; Wodarz et al. 1998) .
In a healthy person, activation following antigenic exposure leads to an increase in the number of T cells speci¢c to that antigen and, concomitantly, to the generation of T cell memory (Burnet 1959; Ahmed & Gray 1996) . However, by infecting activated cells and decreasing their survival the process of antigen clearance may be turned from a source of new cells to a drain (or sink) on the resting CD4 + T cell pool by HIV. Thus, our model predicts that the time-scale of HIV disease progression is set by the rate and duration of antigenic exposure, the resulting number of cells activated and their survival probabilities. The depletion of the quiescent CD4 cell pool is then a result of hundreds of antigenic exposures over many years.
Our model of T cell dynamics links two separate operational time-scales: the slow time-scale of resting T cells and the rapid time-scale of turnover of activated and HIV infected cells, thereby allowing the dynamics of both long-term pathogenesis and post-treatment viral decay to be described. Mathematically, the model is expressed as a system of coupled nonlinear ordinary di¡erential equations de¢ning the dynamics of subpopulations of Tcells:
and
where x 4 and x 8 are the numbers of uninfected resting CD4 + and CD8 + T cells, respectively, x 4a and x 8a are the numbers of activated T cells and v is the HIV viral load. These numbers are normalized so that, in HIVuninfected patients, on average x 4 + x 8 1. The parameters of the model are de¢ned in Figure 1 . Outline of the basic compartmental model. The T cell population is subdivided as shown. However, this apparent simplicity captures in an e¡ective manner the complexity of random antigenic exposure, resulting in multiple antigen-speci¢c clonal cell expansions (Ferguson et al. 1999) , which eventually drive the patient to AIDS. activated CD4 + T cells following the evidence in Stevenson et al. (1990) and Zack et al. (1990) .
The T cell dynamics de¢ned by equations (1)^(4) describe the e¡ect of four basic processes: (i) recruitment of new T cells from the thymus (at rates l 4 and l 8 ), (ii) cell activation by antigens, cell cycling and subsequent division or activation-induced cell death (activation at rates a 4 and a 8 , cycling at rate a with a probability of successful division of p a ), (iii) homeostatic division and death (at rates and Â l 4 + l 8 + + 2a 0 (2p a + 1) chosen so that on average x 4 + x 8 1 at steady state), and (iv) infection of activated CD4 + T cells by HIV (at rate v). The ¢xed probability of activation-induced cell death in the absence of HIV infection ( 17p a ) is the average over a complete T cell response to a speci¢c antigenic stimulus: this probability is low in the early part of an immune response during clonal expansion and increases during clonal contraction (Ahmed & Gray 1996) . That antigenic stimulus results in a substantial net increase in cells while levels of activation-induced cell death are high (Ahmed & Gray 1996) indicates that p a is slightly greater than 0.5.
Intuitive insight into the e¡ect of HIVonTcell dynamics can be obtained by integrating out the rapid time-scales of viral turnover and cell activation (i.e. by averaging over short-term £uctuations in viral load and activated T cell numbers). This in done by taking dx 4a /dt dx 8a /dt dv/ dt 0 in equations (1)^(4). While there is evidence of signi¢cant changes in homeostasis occurring during HIV infection, in particular increases inTcell turnover (Hellerstein et al. 1999) , we ¢nd that in our model these changes (e.g. increasing ) do not qualitatively modify the model predictions. We can thus derive the simple approximate equation for CD4 + Tcell dynamics as The parameter values were chosen consistent with direct estimates (Ho et al. 1995; Wei et al. 1995; Perelson et al. 1996) and in order to generate patterns consistent with data gathered from peripheral blood samples from infected patients. In this scenario, anti-viral therapy must block 4 99.5% of all replication in order to achieve viral suppression. The average basic reproductive numbers are hR 0 i 200 and hR ctl 0 i 8 (the angled brackets denote the average over time). The average lifetime of a productively infected cell after primary infection is 1/h ctl i %1.9 h, but as the CTL e¡ect rapidly fades after the initiation of anti-viral therapy it rapidly extends to 1/ 2days, similar to published estimates (Ho et al. 1995; Wei et al. 1995; Perelson et al. 1996) . For the same reason, our choice of R 0 200 is not inconstant with previous estimates (Nowak et al. 1997; Little et al. 1999) , which calculated only the lower bounds of the basic reproductive number. (c) The evolution of T helper competence in the course of infection. During primary infection I H is very small, resulting in transient symptomatic disease. Competence then recovers to an order of magnitude below normal, with a second slower but persistent drop observed when CD4 counts reach a very low level, corresponding to symptomatic AIDS. However, we do not capture all the features of late-stage AIDS here, such as the sometimes observed increase in viral load and fall in total CD3 + T cell numbers (Margolick et al. 1995) , which could be caused by changes in the tra¤cking patterns between lymphatic tissues and peripheral blood.
In the absence of HIV (v 0) both cell recruitment and cell activation (at respective rates of l 4 and a 4 ) act as sources of new CD4 cells. The e¡ect of HIV is then to reduce the average probability of active CD4 cell division from p a to p a /(1 + v/ a ). Hence, when the viral load v is above the threshold value a (2p a + 1)/ HIV changes antigenic exposure from a source of new CD4 cells to a continuous drain on the CD4 + T cell pool. The logistic dependence of dx 4 /dt on v in equation (5) explains the surprising nonlinearity of the observed dependence on the viral load of patient survival time (i.e. that variations in set-point viral load over a 1000-fold range result in only ¢vefold variations in survival time).
ANTIGENIC EXPOSURE AND T CELL ACTIVATION
The variable a 4 denotes the rate of CD4 activation by all antigens (HIV and non-HIV) and describes the overall e¡ect of multiple clonal T cell responses to many di¡erent antigens over time. What then determines the value of a 4 and, thus, controls the overall rate of progression? In order to explain the steadiness of the decline in CD4, we hypothesize that bursts of activation occur predominantly in localized sites, for example in lymph nodes and in lymphoid patches around the digestive or respiratory tracts. We show in electronic Appendix A that, in the case of localized antigen presentation, the availability of antigen presenting sites is expected to limit the rate of T cell activation, which then occurs at an approximately constant rate. This leads to the following approximation for the rate of CD4 + (subscript i 4) and CD8 + (subscript i 8) Tcell activation:
Here, x S is the T cell density above which the binding process between T cells and antigen presenting sites saturates, a 0 is the average level of T cell activation per antigenic exposure and k i is the number of concurrent antigenic exposures. We incorporate the continuous process of exposure to and clearance of antigens as a simple random process. The dynamics are governed by stochastic equations for the time evolution of the probabilities of k 4 major histocompatibility complex^class II (MHC-II)-restricted and k 8 MHC-I-restricted concurrent antigenic exposures, i.e.
where e i and i are the exposure and clearance rates, respectively. This stochastic system is simulated by generating Poisson-distributed events for ¢xed time-steps and is coupled to the deterministic model by numerically integrating the deterministic equations over the same time-step. Figure 2 shows the combined e¡ect of antigenic stimulation and HIV infection in producing the key features of untreated chronic HIV infection: a steady but variable decline in CD4 + T cells (Phillips et al. 1991) , with a corresponding rise in CD8 + cells (Margolick et al. 1993) , along with a very low prevalence of infected cells (Chun et al. 1997 ).
CD4 CELL DESTRUCTION, HIV VIRAL LOAD AND IMMUNOCOMPETENCE
The relationship between disease progression and immunocompetence can also be described in this framework. Though the interaction between CD4 + T cell help and the e¤cacy of other immune responses has been demonstrated to be important (Battegay et al. 1994; Matloubian et al. 1994; Rosenberg et al. 2000) , the quantitative nature of this interaction has yet to be fully understood. Given the complexity and incomplete understanding of the interaction, we de¢ne a surrogate measure of the competence of the T helper response in the HIVinfected host as the number of activated CD4 T cells available for each antigenic exposure relative to the same quantity pre-HIV infection, namely I H a 4 /k 4 a 0 . At the quasi-steady state, this can be approximated by
This expression states that T helper competence decreases logistically with both decreasing CD4 cell count and increasing HIV viral load and is plotted for a typical model outcome in ¢gure 2c. Since T help is not necessary for the short-term clearance of acute infections (Battegay et al. 1994; Matloubian et al. 1994; Rosenberg et al. 2000) (although it does determine persistence) this expression is not fed back into the model, but rather is taken as a measure of the severity of each antigenic exposure.
HIV VIRAL DYNAMICS AND CTL CONTROL OF HIV
Anti-HIV CTL responses play a central role within our conceptual framework of HIV pathogenesis: although many other arms of the immune system may contribute to controlling HIV (see for example Parren et al. 1999; Rosenberg et al. 2000) , there is increasingly strong evidence suggesting that the CTL response is key (reviewed by McMichael et al. 2000) . While it has been shown that some features of primary infection could be explained solely by the natural epidemic dynamics of HIV expansion and subsequent exhaustion of target cells (Phillips 1996) , our framework agrees with recent studies (Sta¡ord et al. 2000) indicating that the natural history of primary infection (as described by Kaufmann et al. 1998b ) is better explained by the establishment of CTL control of HIV, as shown in ¢gure 2d. This ¢gure also exhibits the establishment of the clinically important long-lived infected cell pool within days of infection (¢gure 2d ), in agreement with recent data (Zhang et al. 1999 ).
Underlying our model of HIV and T cell dynamics is the`basic model of viral dynamics', which was recently reviewed in Nowak & May (2000) . There has also been considerable work extending this model in order to consider many of the issues we discuss here. Our model synthesizes some of these developments, presents novel insights into the processes involved and provides a predictive framework that is both consistent with the rapid time-scale of viral replication and the slow time-scale of HIV immunopathogenesis. First of all, as in Cooper (1986) , McLean & Nowak (1992) , Essunger & Perelson (1994) , Mittler et al. (1996) , Grossman et al. (1998) and Wodarz et al. (1998) , we distinguish between resting and activated CD4 + T cells, with successful infection occurring predominantly in activated cells (Stevenson et al. 1990; Zack et al. 1990 ). Second, we pay close attention to the proliferative dynamics of anti-HIV CTL. We incorporate an e¡ective model of the CTL cell cycle, which was developed in Ferguson et al. (1999) , which results in a bounded proliferation rate that is proportional to a logistic`activity' function e y/( y + y T ), where y is the number of productively infected cells. We have found that the clearance of infected cells is best matched by hypothesizing that anti-HIV CTLs, though long-lived ( 410 days) (Ogg et al. 1999) , are only e¡ectively cytotoxic during the activated phase of their replication cycle. The clearance of infected cells is thus taken to be proportional to e. The dynamics of viral replication are thus determined by the following set of equations:
where y L is the number of long-lived latent infected CD4 + T cells capable of viral production upon activation and z is the number of anti-HIV CTLs. Since free virus is known to be short-lived, the virus load v is assumed to be in equilibrium with y, i.e. we take v by/c, where b is the production rate of virus by productively infected cells and c is the free virus clearance rate. The parameters are described in table 1. Overall, the complete model is de¢ned by equations (1)^(4) and (6)^(11).
THE BASIC REPRODUCTION NUMBER OF HIV
The most fundamental quantity of any model of pathogen dynamics is the basic reproductive number R 0 Nowak & May 2000) , which quanti¢es replicative capacity. Here, it is de¢ned as the number of new virions produced by a single HIV virion in its lifetime in a pool of completely uninfected cells. In the absence of a CTL response its value is given by R 0 a 4 b/ a c. R 0 increases with k (the burst size of an infected cell), a 4 (the rate of CD4 + T cell activation) and (the infectivity of the virus) and decreases with a , c and , which are the rates of CD4 + T cell division, viral clearance and infected cell death, respectively. Since a 4 is a dynamic variable of the model and depends on antigenic exposure, unlike the basic model of viral dynamics (Nowak & May 2000 ; though see Wodarz et al. 1998) , here the basic reproductive number R 0 changes over time.
CTL cytolytic activity increases the death rate of infected cells and results in the following new expression for the reproductive number after maturation of the CTL response: Here d is the death rate of CTLs, p is their maximum proliferation rate and y T is the threshold density of infected cells that is required to trigger CTL proliferation, a quantity that is inversely proportional to CTLs' a¤nity for HIV. That the above expression for R ctl 0 takes the form of the lower of two values re£ects the existence of two distinct dynamical regimes in the model, the ¢rst with no lasting CTL response and the second with a stable e¡ective CTL response: the criterion determining which regime is entered is which of the two expressions de¢ning R ctl 0 is smallest. The death rate of infected cells in the presence of a CTL response is increased from to ctl R 0 /R ctl 0 . This analysis provides further support for the hypothesis that the inability of the CTL response to clear HIV depends critically on the duration of the cytolytic e¡ect immediately following activation by recognition of a viral antigen (Wodarz et al. 2000b) . If this is short, as we suggest above, then CTL lysis of infected cells will rapidly cease as the density of viral antigens drops, thus preventing complete clearance of the virus, but rather maintaining a dynamic equilibrium where viral replication is controlled. Unlike models which do allow clearance of HIV (where the duration of the cytolytic e¡ect is longer), this model reproduces the inverse correlation of anti-HIV CTLs with viral load between patients (Ogg et al. 1998; Dalod et al. 1999; Kalams et al. 1999a ) (see ¢gure 3c), i.e. the positive correlation within a patient (Dalod et al. 1998 (Dalod et al. , 1999 Kalams et al. 1999b; Ogg et al. 1999; Pitcher et al. 1999 ) through time (analysis not shown). The model also captures the relative stability of the viral load throughout HIV infection (Mellors et al. 1996; De Wolf et al. 1997; Lyles et al. 1999 ): most models allowing clearance predict large predator^prey type oscillations in the viral load if clearance fails Nowak & May 2000) . Provided the virus does not mutate and escape this CTL response, this treatment results in lasting increases in CD4 counts.
VARIABILITY BETWEEN HIV PATIENTS
The correlation between HIV viral load and patient survival in untreated infection is well established (Jurriaans et al. 1994; Mellors et al. 1996; de Wolf et al. 1997) . However, since viral loads vary up to 1000-fold between patients and incubation periods by little more than ¢vefold, this correlation is necessarily nonlinear. This key feature of HIV pathogenesis is generated naturally by our model as a consequence of the saturation of infection within the limited pool of activated CD4 + T cells (i.e. the logistic dependence on viral load in equation (5)).
The predicted pattern of variation between patients is illustrated in ¢gure 3. CD4 expression in thymic emigrants and anti-HIV CTL a¤nity are assumed to be log-normally distributed across patients, generating a lognormally distributed viral set-point, which was matched to observations from cohort data (Mellors et al. 1996) . The resulting incubation period distribution predicted by the model agrees with known data (Babiker et al. 2000) , with a median time to AIDS of 8 years (interquartile range 61 3 years). The nonlinear correlation between the set-point viral load and incubation period is demonstrated in ¢gure 3b. This correlation is predicted to be weak as a result of environmental stochasticity in the pattern of patient antigenic exposure. A further prediction of the model is demonstrated in ¢gure 3d. By using thymic output as a surrogate marker for age at infection (Douek et al. 1998) , we predict an inverse correlation between HIV incubation period and age, as has been observed (Babiker et al. 2000) .
We have not modelled evolution in the HIV genome, which will contribute to the progression to AIDS. However, the link between the time-scales of mutation as a function of viral load and long-term pathogenesis has not been clari¢ed in purely evolutionary models (Nowak et al. 1991 . Those models also do not predict several key features of long-term pathogenesis, such as the nonlinear correlation structure illustrated in ¢gure 3b. We therefore do not believe that viral evolution is the primary process explaining pathogenesis, although its potentially important secondary role is the topic of ongoing research.
CLINICAL IMPLICATIONS
As seen in ¢gure 4, the model accurately captures the dynamics of rapid viral turnover in the activated CD4 cell pool as well as a long-lived infected cell pool and, thus, describes the biphasic decay of virus following the initiation of anti-retroviral therapy (Perelson et al. 1996) . Our analysis makes several novel predictions about HIV treatment. First, the model predicts that there is a level of drug e¤cacy which does not reduce viral replication below the self-sustaining threshold (R 0 51) and, thus, is unable to reduce the viral load substantially, but is su¤-cient to lower virus-induced killing of proliferating CD4 cells enough to give a sustained recovery of CD4 cell numbers. This explains`discordant' responses to therapy (Kaufmann et al. 1998a) , as illustrated in ¢gure 4a and furthermore suggests that`discordance' would be eliminated by increasing the potency of treatment.
Second, the basic reproductive number R 0 is not constant, but rather varies randomly with antigenic exposure around a mean value. Thus, when therapy reduces R 0 on average slightly below unity, £uctuations in antigenic exposure can result in periods of sustained viral replication with R 0 41, even in patients known to have good adherence to treatment regimens, as illustrated in ¢gure 4b. We predict that these episodic`bursts' of residual viral replication (Ramratnam et al. 2000) can be suppressed by increasing the potency of therapy, as illustrated in ¢gure 4c. As a corollary, immune stimulation therapy aiming to £ush the long-lived infected cell reservoir with activating cells will also increase R 0 , possibly above unity even under very potent anti-viral drug regimens, an issue that is explored in Fraser et al. (2000) .
Third, when treatment is su¤ciently potent to reduce viral replication below the self-sustaining threshold, CTL cytolytic activity will rapidly cease (declining much faster than the observed decline in anti-HIV CTL numbers), thereby increasing the infected cell lifetime. Hence, ¢rst phase rates of decline (Ho et al. 1995; Wei et al. 1995) are predicted to overestimate the lifetime of infected cells in untreated infection signi¢cantly and, thus, underestimate the steady state rate of turnover of infected cells. Our analysis does not support the hypothesis that the whole of the ¢rst phase of viral decay can be assigned to CTL killing, as in Arnaout et al. (2000) . Initial decays following drug treatment may be slower in primary infection than later in infection, as recently observed in Putter et al. (2000) , although this will only a¡ect the start of the ¢rst phase of viral decay.
Fourth, the CTL model that best matches observed dynamical trends is one that is unable to clear HIV (an equilibrium between CTLs and virus is always reached), but acts to reduce the basic reproductive number R ctl 0 towards unity. CTL action can reduce the viral load su¤ciently to halt the progression to disease: the e¡ect of a treatment strategy that boosts the e¤cacy of the CTL response is illustrated in ¢gure 4d. Such a therapeutic vaccination could be achieved by immunization or by structured treatment interruption, which may act to boost CTL e¤cacy indirectly via increased T helper function (Wodarz & Nowak 1999; Bonhoe¡er et al. 2000; Rosenberg et al. 2000; Wodarz et al. 2000a) . However, viral escape from CTL suppression by mutation could again increase the rate of progression. Hence, improvements in the number and activity of the dominant CTL responses may only have a transient e¡ect. A lasting e¡ect is di¤cult to generate unless the functional CTL response is broad in speci¢city (Harrer et al. 1996; Rosenberg et al. 2000) .
